NCT06109779 2026-03-04Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)AstraZenecaPhase 3 Active not recruiting757 enrolled
NCT06282575 2026-02-24Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract CancerJazz PharmaceuticalsPhase 3 Recruiting286 enrolled
NCT02375880 2025-08-03Study of DKN-01 and Gemcitabine/Cisplatin in Patients With Carcinoma to Primary to the Intra- or Extra-Hepatic Biliary System or GallbladderLeap Therapeutics, Inc.Phase 1 Completed51 enrolled
NCT04003636 2025-04-23KEYNOTE-966Merck Sharp & Dohme LLCPhase 3 Completed1,069 enrolled 19 charts 1 FDA
NCT04066491 2023-11-14Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L BTCEMD SeronoPhase 2/3 Terminated309 enrolled 17 charts
NCT03027284 2020-05-19A Study of Merestinib (LY2801653) in Japanese Participants With Advanced or Metastatic CancerEli Lilly and CompanyPhase 1 Completed19 enrolled